
European Journal of Medicinal Chemistry p. 340 - 347 (2015)
Update date:2022-08-15
Topics:
Abhale, Yogita K.
Sasane, Amit V.
Chavan, Abhijit P.
Deshmukh, Keshav K.
Kotapalli, Sudha Sravanti
Ummanni, Ramesh
Sayyad, Sadikali F.
Mhaske, Pravin C.
A series of 2′-aryl/benzyl-2-aryl-4-methyl-4′,5-bithiazolyl derivatives, 25-64 were synthesized and evaluated for inhibitory activity against Mycobacterium smegmatis MC2 155 strain and antimicrobial activities against four pathogenic bacteria Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Proteus vulgaris. Among them, compounds 40, 49, 50, and 54 exhibited moderate to good inhibition on the growth of the bacteria Mycobacterium smegmatis at the concentration of 30 μM. Compounds 26, 40, 44, 54 and 56 exhibited moderate to good antibacterial activity. Compound 5-(2′-(4-fluorobenzyl)thiazol-4′-yl)-2-(4-fluorophenyl)-4-methyl-thiazole (54) exhibited both antitubercular as well as antimicrobial activity against all tested strains.
View MoreTianjin Emulsion Science&Technology Development Co.,Ltd
Contact:13901380442
Address:Vake Garden New Town New Yi Bai Road Beichen District Tianjin,China
Nanyang Tianhua pharmaceutical Co.,Ltd.
Contact:+8618639816203
Address:Longsheng Industrial Park
Contact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
Contact:+49-9398-993127
Address:Untertorstr. 27
Improve Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Doi:10.1021/om200548s
(2011)Doi:10.1371/journal.pone.0196016
(2018)Doi:10.1023/B:RUCB.0000019883.50477.cc
(2003)Doi:10.1016/j.bmcl.2004.05.090
(2004)Doi:10.1002/hlca.19800630225
(1980)Doi:10.1021/jo00314a029
(1981)